Identification of lung cancer with high sensitivity and specificity by blood testing
Petra Leidinger(Saarland University), Eckart Meese(Saarland University), Andrea Staratschek‐Jox(University of Bonn), Andreas Keller(Helmholtz Institute for Pharmaceutical Research Saarland), Stefanie Rheinheimer(Saarland University), Nicole Ludwig(Saarland University), Veronika Klein(Saarland University), Hanno Huwer, Erich Stoelben(Lungenklinik Köln-Merheim), Ingo Stehle(Saarland University), Jürg Hamacher(University Hospital of Bern), Hans‐Peter Lenhof(Saarland University), Bernhard Stephan(Saarland University), Jürgen Wolf(University of Cologne), Claudia Andrés(Saarland University), Sabrina Heisel
Cited by 39
Related Papers
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k
EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research
|Nature Methods|2017|1.3k
Distribution of miRNA expression across human tissues
|Nucleic Acids Research|2016|1k
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials
|The Lancet Oncology|2019|537